Search

Author/Creator Middleton, M.

11. Preliminary biomarker and pharmacokinetic analysis from the completed dose escalation part of the first-in-human Phase I study evaluating MP0250, a multi-DARPin® blocking HGF and VEGF-A, in patients with advanced solid tumors. (December 2016)

Authors:
Dawson, K.; Feurstein, D.; Fiedler, U.; Kuster, K.; Bez, M.; Schreiner, S.; Turner, D.; Tadjalli Mehr, K.; Stumpp, M.; Harstrick, A.; Baird, R.; Omlin, A.; Middleton, M.; Rodon, J.; Zitt, C.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S133
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Proceedings of the 2013 Spring meeting of the Society of British Neurological Surgeons. (June 2013)

Authors:
Todd, N.; Skinnner, D.; Wilson-Macdonald, J.; Baxter, D. J.; Bradac, O.; Vrana, J.; Jiru, F.; Hrabal, P.; Netuka, D.; Amin, S.; Carter, M.; Edwards, R. J.; Pople, I.; O'Callaghan, F. J. K.; Bradac, O.; Majovsky, M.; Benes, V.; Lunter, C. M.; Gray, W. P.; Smith, M.
Journal:
British journal of neurosurgery
Issue:
Volume 27:Number 3(2013:Jun.)
Page Start:
272
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗